Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Mendes

Showing results (211-220 of 473) with videos related to

Pageof 48
Sort By:
Antimicrobial Agents and Chemotherapy|February 5, 2020
Assessment of Tedizolid <i>In Vitro</i> Activity and Resistance Mechanisms against a Collection of <i>Enterococcus</i> spp. Causing Invasive Infections, Including Isolates Requiring an Optimized Dosing Strategy for Daptomycin from U.S. and European Medical Centers, 2016 to 2018Cecilia G Carvalhaes, Helio S Sader, Robert K Flamm, et al.
The Journal of Antimicrobial Chemotherapy|January 29, 2014
Zyvox® Annual Appraisal of Potency and Spectrum (ZAAPS) program: report of linezolid activity over 9 years (2004-12)Rodrigo E Mendes, Patricia A Hogan, Jennifer M Streit, et al.
Diagnostic Microbiology and Infectious Disease|January 26, 2015
Update of the telavancin activity in vitro tested against a worldwide collection of Gram-positive clinical isolates (2013), when applying the revised susceptibility testing methodRodrigo E Mendes, David J Farrell, Helio S Sader, et al.
Antimicrobial Agents and Chemotherapy|February 4, 2015
Update on linezolid in vitro activity through the Zyvox Annual Appraisal of Potency and Spectrum Program, 2013Rodrigo E Mendes, Patricia A Hogan, Jennifer M Streit, et al.
Microbial Drug Resistance (Larchmont, N.Y.)|August 17, 2022
Antimicrobial Activity of Ceftaroline and Comparator Agents Against Ceftriaxone-Nonsusceptible <i>Streptococcus pneumoniae</i> from the United States (2008-2020)Helio S Sader, Mariana Castanheira, Cecilia G Carvalhaes, et al.
BMC Pulmonary Medicine|January 25, 2025
Activity of Aztreonam-avibactam and other β-lactamase inhibitor combinations against Gram-negative bacteria isolated from patients hospitalized with pneumonia in United States medical centers (2020-2022)Helio S Sader, Rodrigo E Mendes, S J Ryan Arends, et al.
Journal of Veterinary Diagnostic Investigation : Official Publication of the American Association of Veterinary Laboratory Diagnosticians, Inc|July 15, 2026
Intestinal and mesenteric lymphangitis mimicking arteritis in a cow with paratuberculosisDaniel R Rissi, Brianna C Cuellar, Ellen Ruth A Morris, et al.
Antimicrobial Agents and Chemotherapy|April 12, 2012
Transferable plasmid-mediated resistance to linezolid due to cfr in a human clinical isolate of Enterococcus faecalisLorena Diaz, Pattarachai Kiratisin, Rodrigo E Mendes, et al.
Antimicrobial Agents and Chemotherapy|December 21, 2011
Oritavancin activity against vancomycin-susceptible and vancomycin-resistant Enterococci with molecularly characterized glycopeptide resistance genes recovered from bacteremic patients, 2009-2010Rodrigo E Mendes, Leah N Woosley, David J Farrell, et al.
Microbial Drug Resistance (Larchmont, N.Y.)|October 10, 2019
Evaluation of Antimicrobial Effects of a New Polymyxin Molecule (SPR741) When Tested in Combination with a Series of β-Lactam Agents Against a Challenge Set of Gram-Negative PathogensRodrigo E Mendes, Paul R Rhomberg, Troy Lister, et al.
Pageof 48

Showing results (211-220 of 473) with videos related to

Sort By:
Pageof 48
Antimicrobial Agents and Chemotherapy|February 5, 2020
Assessment of Tedizolid <i>In Vitro</i> Activity and Resistance Mechanisms against a Collection of <i>Enterococcus</i> spp. Causing Invasive Infections, Including Isolates Requiring an Optimized Dosing Strategy for Daptomycin from U.S. and European Medical Centers, 2016 to 2018Cecilia G Carvalhaes, Helio S Sader, Robert K Flamm, et al.
The Journal of Antimicrobial Chemotherapy|January 29, 2014
Zyvox® Annual Appraisal of Potency and Spectrum (ZAAPS) program: report of linezolid activity over 9 years (2004-12)Rodrigo E Mendes, Patricia A Hogan, Jennifer M Streit, et al.
Diagnostic Microbiology and Infectious Disease|January 26, 2015
Update of the telavancin activity in vitro tested against a worldwide collection of Gram-positive clinical isolates (2013), when applying the revised susceptibility testing methodRodrigo E Mendes, David J Farrell, Helio S Sader, et al.
Antimicrobial Agents and Chemotherapy|February 4, 2015
Update on linezolid in vitro activity through the Zyvox Annual Appraisal of Potency and Spectrum Program, 2013Rodrigo E Mendes, Patricia A Hogan, Jennifer M Streit, et al.
Microbial Drug Resistance (Larchmont, N.Y.)|August 17, 2022
Antimicrobial Activity of Ceftaroline and Comparator Agents Against Ceftriaxone-Nonsusceptible <i>Streptococcus pneumoniae</i> from the United States (2008-2020)Helio S Sader, Mariana Castanheira, Cecilia G Carvalhaes, et al.
BMC Pulmonary Medicine|January 25, 2025
Activity of Aztreonam-avibactam and other β-lactamase inhibitor combinations against Gram-negative bacteria isolated from patients hospitalized with pneumonia in United States medical centers (2020-2022)Helio S Sader, Rodrigo E Mendes, S J Ryan Arends, et al.
Journal of Veterinary Diagnostic Investigation : Official Publication of the American Association of Veterinary Laboratory Diagnosticians, Inc|July 15, 2026
Intestinal and mesenteric lymphangitis mimicking arteritis in a cow with paratuberculosisDaniel R Rissi, Brianna C Cuellar, Ellen Ruth A Morris, et al.
Antimicrobial Agents and Chemotherapy|April 12, 2012
Transferable plasmid-mediated resistance to linezolid due to cfr in a human clinical isolate of Enterococcus faecalisLorena Diaz, Pattarachai Kiratisin, Rodrigo E Mendes, et al.
Antimicrobial Agents and Chemotherapy|December 21, 2011
Oritavancin activity against vancomycin-susceptible and vancomycin-resistant Enterococci with molecularly characterized glycopeptide resistance genes recovered from bacteremic patients, 2009-2010Rodrigo E Mendes, Leah N Woosley, David J Farrell, et al.
Microbial Drug Resistance (Larchmont, N.Y.)|October 10, 2019
Evaluation of Antimicrobial Effects of a New Polymyxin Molecule (SPR741) When Tested in Combination with a Series of β-Lactam Agents Against a Challenge Set of Gram-Negative PathogensRodrigo E Mendes, Paul R Rhomberg, Troy Lister, et al.
Pageof 48